Delivery Order SPE2DB22D1017-SPE2DB25FF0DC

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,884.86, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,829.79, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of February 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,577.20 firm fixed-price contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,472.95 firm fixed-price contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a medical product, with a completion date of January 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,425.68 fixed-price contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical, through May 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,607.81 firm-fixed-price contract is for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication, with a period of performance through April 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,301.77, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of October 20, 2023. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between...
This is a $2,877.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of April 8, 2025 and was awarded on April 7, 2025. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $9,275.52 and has a completion date of March 4, 2025. It is a firm fixed-price contract for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,413.22 firm fixed-price contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF0DC
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,721.76 firm fixed price contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication, with a completion date of November 29, 2024. The award is not associated with a set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities.

Generated 2/26/25, 10:03 AM